fda compounding semaglutide enforcement october 2025 news issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Phasing Out Compounded GLP-1

This stability is vital for obtaining consistent and reliable results in peptide research, as it supports controlled preparation and multi-dose use across subcutaneous or intramuscular administration routes

Results vary depending on the individual, treatment plan, medical history, and consistency with lifestyle changes

For example, on Wegovy, a patient will start on 0.25 mg once weekly, stay on that dose for four weeks and then progress to 0.5 mg, Dr

These side effects generally improve over time as the body adjusts

Kathleen Valenton, MD, is a Lemme advisory board member

Wipe the rubber stopper with an alcohol wipe and allow it to dry completely